![]() |
市場調査レポート
商品コード
1489436
食品診断市場の2030年までの予測:タイプ別、検査タイプ別、診断システム別、サイト別、汚染物質タイプ別、用途別、地域別の世界分析Food Diagnostics Market Forecasts to 2030 - Global Analysis By Type (Systems, Consumables and Other Types), Testing Type (Safety and Quality), Diagnostics System, Site, Contaminant Type, Application and by Geography |
||||||
カスタマイズ可能
|
食品診断市場の2030年までの予測:タイプ別、検査タイプ別、診断システム別、サイト別、汚染物質タイプ別、用途別、地域別の世界分析 |
出版日: 2024年06月06日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
|
Stratistics MRCによると、世界の食品診断市場は2023年に165億米ドルを占め、予測期間中にCAGR 9.70%で成長し、2030年には315億5,000万米ドルに達する見込みです。
食品の安全性と品質を保証するために、食品診断学は、食品中の汚染物質、病原体、その他の物質の検出と分析を含む重要な分野です。DNA分析、クロマトグラフィー、分光法などの高度な方法を利用することで、研究者はアレルゲン、農薬、細菌、毒素などの可能性のある危険性を検出することができます。さらに、迅速かつ正確な食品診断は、食品を媒介とする感染症を回避し、法令遵守を守り、一般市民の健康を守るために不可欠です。
米国心臓協会によれば、定期的な運動は血中脂質、血圧、体重のコントロールに役立ち、心臓病、脳卒中、糖尿病、ある種のがんを予防し、骨と筋肉を強化し、心理的な幸福感を向上させる。
増加する食中毒
世界人口の増加と都市化に伴い、包装食品や加工食品の消費量が増加しています。残念なことに、細菌、ウイルス、寄生虫などの病原体が食品を汚染した結果、この動向は食中毒の頻度も高めています。さらに、その結果、汚染された商品が顧客に販売される前に、可能性のある危険性を認識し、低減するための効率的な食品診断ソリューションがこれまで以上に必要とされています。
最先端診断ツールの高額費用
技術の向上により、ますます複雑で精密な食品診断技術が生み出される一方で、こうした最先端のツールはしばしば高額になります。小規模な食品企業や研究所にとっては、高度な診断機器やシステムを導入するために必要な初期投資を行うことは法外であると感じるかもしれないです。さらに、これらの技術は、特に新興経済国や小規模食品企業では、継続的なメンテナンス、校正、トレーニング費用などの追加的な経済的負担のために、広く採用されていないです。
新興国市場と食品セクターの急速な開発
食品産業は、都市化、人口増加、消費者の嗜好の変化などさまざまな要因により、世界中で急速に拡大しています。アジア太平洋、ラテンアメリカ、アフリカは、食品診断産業が成長する大きな可能性を秘めた新興市場のひとつです。さらに、これらの地域では経済成長と都市化が進み、包装食品や加工食品の需要が高まっているため、強力な食品安全・品質保証ソリューションが必要とされています。
市場参入と規制遵守への障壁
食品診断企業は、規制当局が施行する厳しい規制や基準のために、事業の拡大や新規市場への参入において課題に直面しています。食品メーカーと診断サービス・プロバイダーは、食品安全性、品質基準、表示要件など、様々に変化する規制の枠組みを遵守する結果、多大な財政的・資源的コストを負担することになります。さらに、国際貿易と市場アクセスは、地域や国によって規制要件が異なり、一貫性がないため、さらに複雑になっています。
食品診断市場は、COVID-19の大流行によってさまざまな影響を受けています。一方では、食品の安全性と衛生が重視されるようになり、食品の品質と安全性を保証するための診断ツールの必要性が高まっています。規制機関、食品製造業者、食品加工業者は、可能性のある汚染物質を見つけ、食品を通じてウイルスが広がるのを阻止するため、検査や観察プログラムを強化しています。しかし、パンデミックはサプライチェーンの混乱を引き起こし、物流問題、労働力不足、生産遅延を引き起こすことで、食品診断用品とサービスの入手可能性とアクセシビリティに影響を及ぼしています。
予測期間中、免疫測定ベースのセグメントが最大となる見込み
食品診断市場は免疫測定ベースの診断薬セグメントによって支配されると予想されます。免疫測定ベースの技術は、標的分析物への抗体の特異的結合に依存しており、食品安全研究所や食品生産施設でのルーチン検査に普及しています。さらに、高感度、迅速な結果、使いやすさなどの利点があります。イムノアッセイベースのキットやプラットフォームは、微生物病原体、毒素、殺虫剤、アレルゲンなど、様々な危害について食品をスクリーニングするために広く使用されています。
予測期間中、病原体分野のCAGRが最も高くなると予想される
食品診断市場の病原体診断セグメントは最も高いCAGRで成長すると予測されます。食品媒介性疾患につながる危険な細菌、ウイルス、寄生虫を検出することが病原体診断の役割であり、食品の安全性を維持するために不可欠です。食中毒患者の増加や食品の安全性に対する懸念の高まりにより、食品中の病原体を迅速かつ正確に検出する方法の必要性が高まっています。さらに、次世代シーケンシング(NGS)、イムノアッセイ、ポリメラーゼ連鎖反応(PCR)のような高度な分子診断技術のおかげで、病原体の検出は革命を遂げており、従来の培養ベースの方法よりも高い感度、特異性、スピードを提供しています。
食品診断市場は北米が支配的です。この地域の優位性は、重要な市場プレーヤーや研究機関の存在、食品安全に関する厳格な規制、洗練されたヘルスケア・インフラなどの複数の要因によるものです。米国農務省(USDA)および食品医薬品局(FDA)は、食品の安全性と品質を保証するために厳格な基準と規制を実施しており、これが高度な食品診断技術に対する需要を促進しています。さらに、この地域における高度診断ソリューションの採用は、食中毒の発生率の上昇と食品の安全性に対する消費者の意識の高まりによっても後押しされています。
食品診断市場はアジア太平洋地域で最も高いCAGRで成長しています。人口拡大、急速な都市化、可処分所得の増加、食品安全法の改正など、数多くの要因がこの成長を後押ししています。消費者の健康志向が高まり、より安全な食品を求めるようになるにつれて、サプライ・チェーン全体を通じて食品の安全性と品質を保証するための堅牢な食品診断ソリューションの必要性が高まっています。さらに、同地域では、食品加工産業の成長、食品取引の世界化、食中毒の増加により、高度な診断技術の採用が推進されています。
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
According to Stratistics MRC, the Global Food Diagnostics Market is accounted for $16.50 billion in 2023 and is expected to reach $31.55 billion by 2030 growing at a CAGR of 9.70% during the forecast period. In order to guarantee food products' safety and quality, food diagnostics is an important field that involves the detection and analysis of contaminants, pathogens, and other substances in food products. By utilizing sophisticated methods like DNA analysis, chromatography, and spectroscopy, researchers can detect possible dangers such as allergens, pesticides, bacteria, and toxins. Moreover, quick and precise food diagnostics are essential for avoiding food borne infections, upholding legal compliance, and protecting the general public's health.
According to the American Heart Association, Regular physical activity helps control blood lipids, blood pressure, and weight; prevents heart disease, stroke, diabetes, and some types of cancer; strengthens bones and muscles and improves psychological well-being.
Growing number of food borne illnesses
The consumption of packaged and processed foods has increased in tandem with the growth in the world's population and urbanization. Unfortunately, as a result of pathogens like bacteria, viruses, and parasites contaminating food products, this trend has also increased the frequency of foodborne illnesses. Additionally, as a result, there is a greater need than ever for efficient food diagnostic solutions to recognize and reduce possible hazards before tainted goods are sold to customers.
High expenses of cutting-edge diagnostic tools
While improvements in technology have resulted in the creation of increasingly complex and precise food diagnostic techniques, these state-of-the-art tools are frequently expensive. Smaller food businesses and laboratories may find it prohibitive to make the initial investment necessary for acquiring and implementing advanced diagnostic equipment and systems. Furthermore, these technologies are not widely adopted, especially in emerging economies and small-scale food enterprises, due to additional financial burdens such as ongoing maintenance, calibration, and training costs.
Rapid development in emerging markets and the food sector
The food industry is expanding rapidly worldwide due to various factors like urbanization, population growth, and shifting consumer preferences. Asia-Pacific, Latin America, and Africa are among the emerging markets that offer substantial potential for the food diagnostics industry to grow. Moreover, strong food safety and quality assurance solutions are required as these areas experience economic growth and urbanization due to the rising demand for packaged and processed foods.
Barriers to market access and regulatory compliance
Food diagnostic companies face challenges in expanding their operations and entering new markets due to strict regulations and standards enforced by regulatory bodies. Food manufacturers and diagnostic service providers bear heavy financial and resource costs as a result of complying with various and changing regulatory frameworks, such as those pertaining to food safety, quality standards, and labeling requirements. Additionally, international trade and market access are further complicated by regional and national regulatory requirements that differ and are inconsistent.
The food diagnostics market has been impacted by the COVID-19 pandemic in a number of ways. On the one hand, there is a greater need for diagnostic tools to guarantee the quality and safety of food products due to the growing emphasis on food safety and hygiene. Regulatory bodies, food producers, and food processors have stepped up testing and observation programs to find possible contaminants and stop the virus from spreading through food. However, the pandemic has caused supply chain disruptions, which have impacted the availability and accessibility of food diagnostic goods and services by creating logistical problems, a labor shortage, and production delays.
The Immunoassay Based segment is expected to be the largest during the forecast period
The market for food diagnostics is expected to be dominated by the immunoassay-based diagnostics segment. Immunoassay-based techniques, which rely on the specific binding of antibodies to target analytes, are popular for routine testing in food safety laboratories and food production facilities. Furthermore, they offer advantages like high sensitivity, rapid results, and ease of use. Immunoassay-based kits and platforms are widely used for screening food products for various hazards, including microbial pathogens, toxins, pesticides, and allergens.
The Pathogens segment is expected to have the highest CAGR during the forecast period
The food diagnostics market's pathogen diagnostics segment is projected to grow at the highest CAGR. Detecting dangerous bacteria, viruses, and parasites that can lead to food borne illnesses is what pathogen diagnostics do, and it is essential to maintaining food safety. The need for quick and precise ways to find pathogens in food products has increased due to the rise in foodborne illness cases and growing worries about food safety. Moreover, pathogen detection has undergone a revolution thanks to advanced molecular diagnostic techniques like Next-Generation Sequencing (NGS), immunoassays, and polymerase chain reaction (PCR), which offers higher sensitivity, specificity, and speed than conventional culture-based methods.
The market for food diagnostics is dominated by North America. The region's dominance is ascribed to multiple factors, such as the existence of important market players and research institutions, strict regulations pertaining to food safety, and sophisticated healthcare infrastructure. The United States Department of Agriculture (USDA) and the Food and Drug Administration (FDA) enforce strict standards and regulations to guarantee the safety and quality of food products, which fuels the demand for advanced food diagnostic technologies. Additionally, the adoption of advanced diagnostic solutions in the region has also been fueled by rising foodborne illness incidence and heightened consumer awareness of food safety.
The market for food diagnostics is growing at the highest CAGR in the Asia-Pacific region. Numerous factors are driving this growth, such as population expansion, fast urbanization, rising disposable incomes, and changing food safety laws. Robust food diagnostic solutions are becoming increasingly necessary to guarantee food safety and quality throughout the supply chain as consumers become more health-conscious and demand safer food products. Furthermore, the region's adoption of advanced diagnostic technologies is being propelled by the growth of the food processing industry, the globalization of food trade, and the increasing prevalence of foodborne illnesses.
Key players in the market
Some of the key players in Food Diagnostics market include Biomerieux Sa, Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, 3M Company, Randox Food Diagnostics, Shimadzu Corporation, Bio-Rad Laboratories, Inc., Neogen Corporation, Ring Biotechnology Co Ltd., Agilent Technologies Inc., Nemis Technologies AG, Clear Labs, Inc., PerkinElmer Inc. and Biorex Food Diagnostics.
In April 2024, Merck KGaA Darmstadt, Germany entered into a licensing agreement with Inspirna, Inc. for ompenaclid (RGX-202), a first-in-class oral inhibitor of the creatine transport channel SLC6A8, and SLC6A8-targeting follow-on compounds. Ompenaclid is currently being evaluated in a Phase II study for the second-line treatment of RAS-mutated (RASmut) advanced or metastatic colorectal cancer (mCRC).
In October 2023, To support emerging precision therapies and improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targeted cancer treatments, Thermo Fisher Scientific today announced a companion diagnostic (CDx) partnership with Boehringer Ingelheim. Through this collaboration, the companies will work to develop CDx tests to help identify patients with non-small cell lung cancer (NSCLC) with specific genomic mutations.
In August 2023, Science and medical technology firm Danaher announced that it has entered into an agreement to acquire Abcam, a Cambridge, U.K.-based supplier of antibodies, reagents, biomarkers, and assays. Under the agreement, Danaher will acquire all outstanding Abcam shares for $24 per share in cash, with a total enterprise value of approximately $5.7 billion, including Abcam's assumed debts and net of acquired cash.